New weight loss drug decreases appetite without nausea — and can even burn calories
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
The Boston Globe1mon
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are ... up from $125 million in 2022. Already in 2022, GLP-1 drugs accounted for 5 percent of pharmacy spending among people ...
News Medical on MSN3d
Scientists discover new breakthrough in weight loss and diabetes treatment
Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...
Scientific American23d
Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
The new weight-loss drugs have created “a hope and optimism ... by at least 5 percent in most participants after 56 weeks. A 2022 trial of 201 teens aged 12 to 18 reported a higher treatment ...
Reuters18d
US FDA says lowest dose of Novo Nordisk's weight-loss drug now available
Oct 30 (Reuters) - The lowest dose of Novo Nordisk's (NOVOb.CO), opens new tab weight-loss drug ... on the U.S. Food and Drug Administration's shortage list since early 2022.
Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.